Request Deal Involvement

Varian Biopharmaceuticals to go public via a SPAC merger with SPK Acquisition in a $116m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Dorsey & Whitney

legal advisors

Dorsey & Whitney

Loeb & Loeb

legal advisors

Loeb & Loeb

LifeSci Partners

financial advisors

LifeSci Partners

LifeSci Partners

pr advisors

LifeSci Partners

or

Principals

VARIAN BIOPHARMACEUTICALS

target

VARIAN BIOPHARMACEUTICALS

SPK ACQUISITION CORP

bidder

SPK ACQUISITION CORP

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Varian Biopharmaceuticals to go public via a SPAC merger with SPK Acquisition in a $116m.